Frankfurt - Delayed Quote EUR

Context Therapeutics Inc. (6K9.F)

Compare
0.7450
0.0000
(0.00%)
At close: February 18 at 8:07:20 AM GMT+1
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
32,546.6830
25,072.6160
14,881.2030
7,437.9870
2,572.1680
Operating Income
-32,546.6830
-25,072.6160
-14,881.2030
-7,437.9870
-2,572.1680
Net Non Operating Interest Income Expense
2,460.9070
1,163.9750
547.2680
-64.2400
-661.2240
Other Income Expense
-66.3060
-55.5700
-502.0040
-2,954.6430
9,877.8570
Pretax Income
-30,152.0820
-23,964.2110
-14,835.9390
-10,456.8700
6,644.4650
Net Income Common Stockholders
-30,152.0820
-23,964.2110
-14,835.9390
-10,456.8700
1,070.9070
Average Dilution Earnings
--
--
--
--
-9,216.6330
Diluted NI Available to Com Stockholders
-30,152.0820
-23,964.2110
-14,835.9390
-10,456.8700
-8,145.7260
Basic EPS
-0.88
-1.50
-0.93
-3.69
0.10
Diluted EPS
-0.88
-1.50
-0.93
-3.69
-0.80
Basic Average Shares
41,925.1000
15,966.0530
15,966.0530
2,833.6740
10,209.7920
Diluted Average Shares
41,925.1000
15,966.0530
15,966.0530
2,833.6740
10,209.7920
Total Operating Income as Reported
-32,546.6830
-25,072.6160
-15,381.2030
-10,525.8190
-2,572.1680
Total Expenses
32,546.6830
25,072.6160
14,881.2030
7,437.9870
2,572.1680
Net Income from Continuing & Discontinued Operation
-30,152.0820
-23,964.2110
-14,835.9390
-10,456.8700
6,644.4650
Normalized Income
-30,152.0820
-23,964.2110
-14,335.9390
-7,378.3550
-566.3706
Interest Income
2,460.9070
1,163.9750
547.2680
--
--
Interest Expense
--
--
--
64.2400
661.2240
Net Interest Income
2,460.9070
1,163.9750
547.2680
-64.2400
-661.2240
EBIT
-32,546.6830
-25,072.6160
-14,881.2030
-10,392.6300
7,305.6890
EBITDA
-32,536.1680
-25,060.5720
-14,871.9350
-10,392.6300
7,305.6890
Reconciled Depreciation
10.5150
12.0440
9.2680
--
--
Net Income from Continuing Operation Net Minority Interest
-30,152.0820
-23,964.2110
-14,835.9390
-10,456.8700
6,644.4650
Total Unusual Items Excluding Goodwill
--
--
-500.0000
-3,078.5150
9,877.8570
Total Unusual Items
--
--
-500.0000
-3,078.5150
9,877.8570
Normalized EBITDA
-32,536.1680
-25,060.5720
-14,371.9350
-7,314.1150
-2,572.1680
Tax Rate for Calcs
--
--
--
--
0.0003
Tax Effect of Unusual Items
--
--
--
--
2,667.0214
12/31/2020 - 11/30/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6XY.F HBM Holdings Limited
0.5950
+10.19%
 
CRO.BE Open Orphan PLC
0.2120
0.00%
 
CRO.DU hVIVO PLC
0.1920
0.00%
 
PHPN.F Galectin Therapeutics Inc.
1.4200
+10.08%
 
1U5.F Wave Life Sciences Ltd.
10.20
-1.92%
 
OPORF hVIVO plc
0.2400
-31.43%
 
CRO.F hVIVO plc
0.1860
-19.83%
 
EU6.F PDS Biotechnology Corporation
1.4950
+0.47%
 
RFM.F Sensorion SA
0.6000
+0.67%
 
ALTME.PA TME Pharma N.V.
0.0755
-2.20%